Endoüroloji Bülteni
Yazarlar: Selahattin BEDİR, Engin KAYA, Serdar YALÇIN, Murat ZOR
Konular:Üroloji ve Nefroloji
Anahtar Kelimeler:MR-US Fusion Biopsy,Prostate Cancer
Özet: Today, the most important indication for multiparametric prostate magnetic resonance imaging (mp-MRI) assisted targeted biopsies is the presence of previously negative biopsy but still clinically suspected cancer. Currently, both the European Association of Urology and the American Association of Urology recommend that targeted biopsy with systemic biopsy be performed in patients with suspected prostate cancer and previous negative prostate biopsy. Targeted prostate biopsies can be grouped under 2 headings. The first is an in-gantry biopsy, which is defined as direct biopsy under magnetic resonance (MR) image while the patient is in a MR gantry device, while the other is MR-US fusion biopsies (FB) performed by cognitive or software-assisted fusion of the MR image and transrectal ultrasound (TRUS). In this review, we will discuss software-assisted MR-US FB techniques, their results and our own clinical experience. This article has been compiled under the titles of MR-US fusion biopsy techniques, cognitive MR-US fusion prostate biopsy, software-assisted MR-US FB and results.